USA

The software works with both dual-source and photon-counting CT scanners to provide advanced diagnostic capabilities.

The therapy delivers the full-length human frataxin gene using a dual-administration approach that combines direct intradentate nucleus (IDN) injection with intravenous (IV) infusion.

Regeneron is investing USD 150 million in equity and upfront payments to acquire half of the global development and commercialization rights for TSRA-196.

LumiGuide enables physicians to visualize and guide devices inside the body using light instead of continuous X-ray imaging.

Each year in the United States, more than 20 million abdomen-pelvis CT scans are performed, and the volume continues to increase.

Philips has pioneered helium-free MRI technology, installing over 2,000 of its 1.5T BlueSeal MRI systems globally and conserving more than 6 million liters of liquid helium.

The acquisition centers on Alcyone’s innovative ThecaFlex DRx drug delivery system, an experimental implantable device that represents a significant advancement in treating neurological disorders.

Construction at the MTC is currently underway and is scheduled for completion during the first half of 2027.

GEN1160 now joins GEN1107 on Genmab’s list of discontinued assets from the April 2024 ProfoundBio acquisition.

The pharmaceutical giant will pay USD221.50 per share in cash to purchase the US biotech company, which has developed an innovative platform called drug-Fc conjugates (DFCs).